Cytogel is a clinical stage bio-pharmaceutical company developing first in class drug candidates from the novel endomorphin family of molecules, that target key pain pathways and alleviate pain. This groundbreaking approach is backed by new technology to deliver treatment to people in pain. Learn how we’re reinventing pain management.
View Top Employees from Cytogel Pharma, LLCWebsite | http://www.cytogelpharma.com |
Revenue | $811000 |
Funding | $5.6 million |
Employees | 8 (3 on RocketReach) |
Founded | 2006 |
Address | 3 Thorndale Circle, Darien, Connecticut 06820, US |
Phone | (203) 966-9867 |
Industry | Biotechnology, Biotechnology Research, Manufacturing General, Biopharma, Manufacturing, Drug Discovery, Health Care, Science and Engineering |
Competitors | Amneal Pharmaceuticals, Contract Pharma, Lannett Company, Inc., Pharmaceutical Executive, Theragene Pharmaceuticals |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular Cytogel Pharma, LLC employee's phone or email?
The Cytogel Pharma, LLC annual revenue was $811000 in 2024.
Alan Dunton is the Director of Cytogel Pharma, LLC.
3 people are employed at Cytogel Pharma, LLC.
Cytogel Pharma, LLC is based in Darien, Connecticut.
The NAICS codes for Cytogel Pharma, LLC are [3254, 325, 32, 32541].
The SIC codes for Cytogel Pharma, LLC are [28, 283].